In the third instalment of our series on Diversity & Inclusion (D&I;) in Financial Services, Hannah Mahon and James England discuss the fine distinction between lawful “positive action” and unlawful “positive discrimination” under the Equality Act 2010.

What is the difference between positive action and positive discrimination? | D&I in Financial Services

Our Eversheds Sutherland Legal Insights channel has been designed to allow you to listen to our podcasts wherever and whenever it is most convenient. 

We streamline instant access to legal developments which enables you to find specific and relevant insights of interest in one convenient place.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

Management

Tune in to our inaugural episode of our new podcast series on Private Equity trends in Europe. Partners Matthew Allen and James Trevis discuss our Private Equity team's recent win at the Real Deals Private Equity Awards, highlight some recent key deals we have advised on, and what the future holds for the team.

Private equity trends in Europe Episode 1 – A pan European perspective

In the ninth episode in this series, we are joined by John Pruitt in New York and Martin Mankabady in London for a discussion on AI use cases and regulation in the insurance industry.

The Future of Financial Services: Decoding AI - Episode 9: Perspectives on the insurance industry

In our eighth episode we are joined by Ann Fort (US Intellectual Property Partner) and David Wilkinson (UK Company Commercial Partner) for a discussion on Intellectual Property and Anti-Trust. Designed to help you look beyond the headlines and hype cycle, this series will help you make the most of the significant opportunity AI brings on an informed basis, taking into account the rapidly evolving legal, regulatory and risk and control frameworks in which the financial services industry operates.

The Future of Financial Services: Decoding AI - Episode 8: Perspectives on Intellectual Property and Anti-Trust

Utilizing health data requires health and life sciences companies to tread a fine line between innovation and protecting patient privacy. Listen to the latest episode in our Data as an Asset podcast series, where we outline:  key US, EU and UK regulations global health and life sciences companies need to be aware of,   the obstacles and opportunities for research, product development, patients and the public good and  AI's potential for healthcare innovation

Data as an Asset: Utilizing data in the health and life sciences industry

Having first been introduced in the House of Commons 13 months ago, the UK Digital Markets, Competition and Consumers (#DMCC) Act received Royal Assent today. In this podcast, Julia Woodward-Carlton and Annabel Borg explain how the new regime will proceed and what businesses need to do to comply.

What is the difference between positive action and positive discrimination? | D&I in Financial Services

Download our free app to listen on your phone